Rosiglitazone On the Ropes

A week ago, MedPageToday reported that a British advisory commission recommended the diabetes drug rosiglitazone (Avandia) be withdrawn from the market.

On July 6, I wrote about evidence that rosiglitazone users seem to incur a higher risk of stroke, heart failure, and death.

If I were taking Avandia, I’d be asking my doctor about alternatives. 

Steve Parker, M.D.


Filed under Drugs for Diabetes

2 responses to “Rosiglitazone On the Ropes

  1. Pingback: Rosiglitazone On the Ropes | Blood Glucose Test Strips

  2. Pingback: R.I.P., Rosiglitazone | Diabetic Mediterranean Diet